Literature DB >> 28315995

Ligand-based virtual screening under partial shape constraints.

Mathias M von Behren1, Matthias Rarey2.   

Abstract

Ligand-based virtual screening has proven to be a viable technology during the search for new lead structures in drug discovery. Despite the rapidly increasing number of published methods, meaningful shape matching as well as ligand and target flexibility still remain open challenges. In this work, we analyze the influence of knowledge-based sterical constraints on the performance of the recently published ligand-based virtual screening method mRAISE. We introduce the concept of partial shape matching enabling a more differentiated view on chemical structure. The new method is integrated into the LBVS tool mRAISE providing multiple options for such constraints. The applied constraints can either be derived automatically from a protein-ligand complex structure or by manual selection of ligand atoms. In this way, the descriptor directly encodes the fit of a ligand into the binding site. Furthermore, the conservation of close contacts between the binding site surface and the query ligand can be enforced. We validated our new method on the DUD and DUD-E datasets. Although the statistical performance remains on the same level, detailed analysis reveal that for certain and especially very flexible targets a significant improvement can be achieved. This is further highlighted looking at the quality of calculated molecular alignments using the recently introduced mRAISE dataset. The new partial shape constraints improved the overall quality of molecular alignments especially for difficult targets with highly flexible or different sized molecules. The software tool mRAISE is freely available on Linux operating systems for evaluation purposes and academic use (see http://www.zbh.uni-hamburg.de/raise ).

Keywords:  3D similarity searching; Lead discovery; Ligand-based; Molecular similarity; Partial shape; Structural alignment; User-defined constraints; Virtual screening

Mesh:

Substances:

Year:  2017        PMID: 28315995     DOI: 10.1007/s10822-017-0011-z

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  20 in total

Review 1.  Docking and scoring in virtual screening for drug discovery: methods and applications.

Authors:  Douglas B Kitchen; Hélène Decornez; John R Furr; Jürgen Bajorath
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

2.  A novel search engine for virtual screening of very large databases.

Authors:  David Vidal; Michael Thormann; Miquel Pons
Journal:  J Chem Inf Model       Date:  2006 Mar-Apr       Impact factor: 4.956

3.  ShaEP: molecular overlay based on shape and electrostatic potential.

Authors:  Mikko J Vainio; J Santeri Puranen; Mark S Johnson
Journal:  J Chem Inf Model       Date:  2009-02       Impact factor: 4.956

4.  Pharao: pharmacophore alignment and optimization.

Authors:  Jonatan Taminau; Gert Thijs; Hans De Winter
Journal:  J Mol Graph Model       Date:  2008-04-11       Impact factor: 2.518

5.  Fast protein binding site comparison via an index-based screening technology.

Authors:  Mathias M von Behren; Andrea Volkamer; Angela M Henzler; Karen T Schomburg; Sascha Urbaczek; Matthias Rarey
Journal:  J Chem Inf Model       Date:  2013-02-07       Impact factor: 4.956

Review 6.  Virtual screening strategies in drug discovery: a critical review.

Authors:  A Lavecchia; C Di Giovanni
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

7.  mRAISE: an alternative algorithmic approach to ligand-based virtual screening.

Authors:  Mathias M von Behren; Stefan Bietz; Eva Nittinger; Matthias Rarey
Journal:  J Comput Aided Mol Des       Date:  2016-08-26       Impact factor: 3.686

8.  Structure-based inhibitor design of AccD5, an essential acyl-CoA carboxylase carboxyltransferase domain of Mycobacterium tuberculosis.

Authors:  Ting-Wan Lin; Melrose M Melgar; Daniel Kurth; S Joshua Swamidass; John Purdon; Teresa Tseng; Gabriela Gago; Pierre Baldi; Hugo Gramajo; Shiou-Chuan Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

9.  Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.

Authors:  Michael M Mysinger; Michael Carchia; John J Irwin; Brian K Shoichet
Journal:  J Med Chem       Date:  2012-07-05       Impact factor: 7.446

10.  Anti-SARS drug screening by molecular docking.

Authors:  D-Q Wei; R Zhang; Q-S Du; W-N Gao; Y Li; H Gao; S-Q Wang; X Zhang; A-X Li; S Sirois; K-C Chou
Journal:  Amino Acids       Date:  2006-05-22       Impact factor: 3.520

View more
  1 in total

1.  Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer.

Authors:  Faez Iqbal Khan; Dakun Lai; Razique Anwer; Iffat Azim; Mohd Kalim Ahmad Khan
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.